
Imagene is a SaaS enterprise solution utilizing AI to advance translational research and drive progress in drug development and clinical trials. At its core is their state-of-the-art Oncology Intelligence Foundation Model, a scalable and versatile backbone for diverse oncology applications. They aim to transform cancer research and diagnostics by unlocking the power of oncology intelligence, translating complex tissue patterns into actionable insights. Imagene's offerings include OI Suite and Lung OI, an AI-based NSCLC molecular panel for rapid biomarker profiling. The company emphasizes a patient-first mindset and is committed to advancing precision oncology.

Imagene is a SaaS enterprise solution utilizing AI to advance translational research and drive progress in drug development and clinical trials. At its core is their state-of-the-art Oncology Intelligence Foundation Model, a scalable and versatile backbone for diverse oncology applications. They aim to transform cancer research and diagnostics by unlocking the power of oncology intelligence, translating complex tissue patterns into actionable insights. Imagene's offerings include OI Suite and Lung OI, an AI-based NSCLC molecular panel for rapid biomarker profiling. The company emphasizes a patient-first mindset and is committed to advancing precision oncology.